Genotyping is a specific technology used for identifying the genetic variations in an individual’s genomic sequence or allelic genes by comparing them to the reference sequence. Genotyping generally helps to explore the genetic variants such as structural changes in the DNA and single nucleotide polymorphism (SNPs). Genotyping assay verifies the genetic differences by comparing the DNA sequence to that of another sample or reference sequence. It is crucial because it helps in studying the population genomics, agricultural traits, disease association, and microorganisms. It can be usually conducted with the help of polymerase chain reaction (PCR), microarray, electrophoresis and MALDI-TOF. Growth of the genotyping assay market is mainly attributed to surging technological advancements in genotyping assay platforms, increasing demand for personalized medicine, and rising prevalence of chronic diseases.
Referring to the study, Global Genotyping Assay Industry Research Report 2021 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2027. Some of the key companies operating in the global genotyping assay market include Thermo Fisher Scientific, Qiagen, Brooks Automation (Genewiz), Danaher, Pacific Biosciences of California, GE, Illumina, Fluidigm, Agilent Technologies, Roche,Perkinelmer, Bio-Rad Laboratories, Eurofins Scientific and among others.
Based on types, global genotyping assay market can be segmented as reagents & kits and instruments. Genotyping assay reagents & kits segment dominates the global market because they are generally used in genomic & genetic research. They determine the genotype of a certain individual using one or more DNA markers. Genotyping assay reagents & kits are important ingredients of the genotyping assay. These components are usually used to identify, measure & analyze the genetic variation in DNA samples. Additionally, genotyping assay instruments segment is expected to witness higher growth rate as they are used to detect & genotype variants in DNA during the forecast period. In addition, based on application, market can be segmented as diagnostic & research laboratories, pharmaceutical & biopharmaceutical companies, academic institutes and others.
Request for Sample Report –https://kenresearch.com/sample-report.php?Frmdetails=NDQ0NzA0
Increase in incidence of genetic diseases and rise in awareness on personalized medicine, followed by growth in technological advancements & decrease in prices of DNA sequencing, increase in the number of hereditary sicknesses among individuals, rise in demand for bioinformatics solutions in data analysis and increase in importance of genotyping in drug development are some major factors, which are responsible for growth of the genotyping assay market. Apart from this, high cost of equipment used in genotyping may impact the market. Moreover, increase in application areas of genotyping, growth in importance of sequencing projects and rise in demand for genome analysis in plant & animal livestock are leading opportunities for global market.
Based on regional analysis, the North-America is a leading region in global genotyping assay market owing to rise in incidence of genetic diseases & immediate measures across the region. The Asia-Pacific and Europe regions are estimated to witness higher growth rate due to improved healthcare and medical facilities, large population base coupled with developing medical infrastructure over the forecast period. It is projected that future of the global genotyping assay market will be bright on account of increase in importance & awareness of drug development and surge in the drug development during the forecast period.
For More Information, refer to below link:-
Global Genotyping Assay Market Research Report
Related Reports
Follow Us
LinkedIn | Instagram | Facebook | Twitter | YouTube
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249
